Financial statements Incapharma Poland

Balance sheet of Incapharma Poland

Company age:
Age:
16 y. 2 m. 16 d.
Share capital:
Share capital:
131 800 PLN
Profit and loss statement Balance Profitability

Balance sheet data of INCAPHARMA POLAND

Year
2018
2019
2020
2021
2022
Total assets 174 166,33 208 551,52 287 599,54 299 096,56 293 678,27
A. Fixed assets 138 700,00 138 700,00 90 800,00 90 800,00 90 800,00
B. Current assets 35 466,33 69 851,52 196 799,54 208 296,56 202 878,27
C. Share capital contributions (basic funds) - - 0,00 0,00 0,00
D. Own shares (stocks) - - 0,00 0,00 0,00
Total liabilities 174 166,33 208 551,52 287 599,54 299 096,56 293 678,27
A. Equity 50 936,19 83 866,02 25 267,79 49 690,71 -69 047,55
B. Liabilities and provisions for liabilities 123 230,14 124 685,50 262 331,75 249 405,85 362 725,82
I. Long-term liabilities 0,00 0,00 0,00 0,00 321 395,69
II. Short-term liabilities 123 230,14 124 685,50 224 020,83 249 405,85 41 330,13
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.